1
0
0
(1 - 38 von 42
)
New targeted alpha therapy protocol for advan | EurekAlert!
www.eurekalert.org
... Frank Bruchertseifer, Christos Apostolidis, and Alfred Morgenstern, Directorate for Nuclear Safety and Security, European Commission, Joint ...
Novel radioligand therapy proven superior for - EurekAlert!
www.eurekalert.org
— ... and Nuclear Medicine Research Infrastructure, Pretoria, South Africa; Frank Bruchertseifer, European Commission, Joint Research Centre, ... › news-...
Targeted Alpha Therapy Symposium (1-5 April 2019): Contribution ...
meetings.triumf.ca
Details for Frank Bruchertseifer. Title: Dr. Affiliation: European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security ... › author
Kratochwil, Clemens: Targeted alpha therapy of mCRPC - HEIDI
katalog.ub.uni-heidelberg.de
von C Kratochwil · — Verf.angabe: Clemens Kratochwil, Karl Schmidt, Ali Afshar-Oromieh, Frank Bruchertseifer, Hendrik Rathke, Alfred Morgenstern, Uwe Haberkorn, ... › titel
EANM: Eckert & Ziegler award nuclear medicine grants
healthimaging.com
Frank Bruchertseifer, PhD, Germany: In vitro and in vivo comparison of 226Th- and 213Bi-labelled radioconjugates for targeted alpha therapy. Giampiero Giovacchini, MD, PhD
9th Symposium on Targeted Alpha Therapy
events.r20.constantcontact.com
Please join our 9th Symposium on Targeted Alpha Therapy in Warswaw, Poland!
7th Symposium on Targeted Alpha Therapy
events.r20.constantcontact.com
Christos Apostolidis, Frank Bruchertseifer, Alfred Morgenstern (JRC-ITU, Karlsruhe) Further information will be available at http://itu.jrc.ec.europa.eu/ www
Frank Bruchertseifer | XanEdu Customization Platform
www.academicpub.com
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in α-emitter therapy for ...
Clinical Applications of Nuclear Medicine Targeted Therapy
books.google.cz
465 Jolanta Kunikowska, Alfred Morgenstern, Frank Bruchertseifer, and Leszek Krolicki 36 CXCR4-Directed Endoradiotherapy as New Treatment Option in Advanced ...
Alpha- versus Beta-Particle Radiopeptide Therapy in a ...
aacrjournals.org
von D Wild · · Zitiert von: 134 — Frank Bruchertseifer;. Frank Bruchertseifer. Authors' Affiliations: 1Division of Radiological Chemistry, University Hospital, Basel, Switzerland; ... › cancerres
Targeted Alpha Therapy with 213Bi: Ingenta Connect
www.ingentaconnect.com
Alfred Morgenstern*, Frank Bruchertseifer and Christos Apostolidis. European Commission, Joint Research Centre, Institute for Transuranium Elements, PO Box ...
New targeted alpha therapy protocol for advanced prostate cancer
www.sciencedaily.com
Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Marcus Bronzel, Christos Apostolidis, Wilko Weichert, Uwe Haberkorn, Frederik L.
Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of...
link.springer.com
Targeted therapy with α-particle emitting radionuclides is a promising new option in cancer therapy. Stable conjugates of the vascular tumour-homing p
Functionalized NaA nanozeolites labeled with 224,225 Ra for targeted...
link.springer.com
The 223Ra, 224Ra, and 225Ra radioisotopes exhibit very attractive nuclear properties for application in radionuclide therapy. Unfortunately the lack of app
Frank Bruchertseifer_爱学术 - 爱学术搜索s.ixueshu.com › ...
www.ixueshu.com
搜索结果：找到“ Frank Bruchertseifer”相关结果4条. 年份. 期刊级别. 语言: 英文 (4). 关键词: anti-tumor response (1): immunotherapy (1): irradiation (1): radiation ...
9th Symposium on Targeted Alpha Therapy, Warsaw - Politieke monitor
www.parlementairemonitor.nl
Targeted Alpha Therapy Research at JRC-ITU
© EU 2014
An Overview of Targeted Alpha Therapy with 225 Actinium ...
pubmed.ncbi.nlm.nih.gov
von A Morgenstern · · Zitiert von: 157 — Authors. Alfred Morgenstern , Christos Apostolidis , Clemens Kratochwil , Mike Sathekge , Leszek Krolicki , Frank Bruchertseifer ... von A Morgenstern · · Zitiert von: 43 — Authors. Alfred Morgenstern , Christos Apostolidis , Frank Bruchertseifer. Affiliations. 1 European Commission, Joint Research Centre, Directorate for ... › ...
An Overview of Targeted Alpha Therapy with 225
www.eurekaselect.com
... Medical University Warsaw, Warsaw, Poland Frank Bruchertseifer European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, ...
Cureus | α-Radioimmunotherapy with 213Bi-anti-CD38 immunoconjugates...
www.cureus.com
... Endell, Rainer Boxhammer, Stephane Leclair, Mario Vallon, Michaela Aichler, Annette Feuchtinger, Frank Bruchertseifer, Alfred Morgenstern, Markus Essler ...
Development of Targeted Alpha Therapy from Bench to Bedside - PubMed
pubmed.ncbi.nlm.nih.gov
This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours,...
Radioimmunotherapy Is More Effective than Antifungal ...
academic.oup.com
von RA Bryan · · Zitiert von: 67 — Frank Bruchertseifer,. Frank Bruchertseifer. 4. European Commission, Joint Research Centre, Institute for Transuranium Elements. ,. Karlsruhe, Germany. › jid › ar...
Combining α-Radioimmunotherapy and Adoptive T Cell ...
hal.archives-ouvertes.fr
von J Ménager · · Zitiert von: 31 — Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction · Alfred Morgenstern · Frank Bruchertseifer · François Davodeau · Joëlle ... › in...
Targeted Alpha Therapy of mCRPC with 225Actinium-PSMA617
jnm.snmjournals.org
von F Bruchertseifer · · Zitiert von: 1 — Frank Bruchertseifer, Alfred Morgenstern, Frederik Giesel, Christos Apostolidis, Uwe Haberkorn and Clemens Kratochwil. Journal of Nuclear Medicine May 2018, ... von M Sathekge · — Mike Sathekge, Frank Bruchertseifer, Mariza Vorster, Ismaheel Lawal, Otto Knoesen, Johncy Mahapane, Cindy Davis, Amanda Mdlophane, ... › content › early
Radioimmunotherapy is more effective than antifungal ...citeseerx.ist.psu.edu › viewdoc › summary
citeseerx.ist.psu.edu
by Ruth A. Bryan , Zewei Jiang , Robertha C. Howell , Alfred Morgenstern , Frank Bruchertseifer , Arturo Casadevall , Ekaterina Dadachova ...
Optimizing the treatment regimen for targeted alpha therapy of ...
jnm.snmjournals.org
von F Bruchertseifer · · Zitiert von: 4 — Frank Bruchertseifer, Clemens Kratochwil, Hendrik Rathke, Uwe Haberkorn, Alfred Morgenstern and Frederik Giesel. Journal of Nuclear Medicine May 2019, ... › content
Influence of tumour size on the efficacy of targeted alpha therapy...
ejnmmires.springeropen.com
Author Frank Bruchertseifer declares that he has no conflict of interest. Author Wouter A. Breeman owns stock in AAA. Author Marion de Jong is the chair of the ...
Supply and Clinical Application of Actinium-225 and Bismuth ...
www.researcher-app.com
Alfred Morgenstern, Christos Apostolidis, Frank Bruchertseifer. The recent development of 225Ac-PSMA617 for therapy of prostate cancer has strikingly ... › ...
Targeted alpha therapy of mCRPC: Dosimetry estimate of
europepmc.org
von C Kratochwil · · Zitiert von: 99 — 1 Karl Schmidt,2 Ali Afshar-Oromieh,1Frank Bruchertseifer,3 Hendrik Rathke,1 Alfred Morgenstern,3 Uwe Haberkorn,1,4 and Frederik L. Giesel › pmc
versus beta-particle radiopeptide therapy in a human prostate ...
profiles.wustl.edu
von D Wild · · Zitiert von: 134 — Damian Wild, Michael Frischknecht, Hanwen Zhang, Alfred Morgenstern, Frank Bruchertseifer, Julie Boisclair, Anne Provencher-Bolliger, ... › alpha-v...
and 177Lu-radiation for peptide receptor radionuclide therapy
journals.plos.org
— Frank Bruchertseifer,. Roles Resources, Validation, Writing – review & editing. Affiliation European Commission, Joint Research Centre, ... › comments
Radioimmunotherapy of fungal infection with 213Bi-labeled antibody...
jhu.pure.elsevier.com
... of fungal infection with 213Bi-labeled antibody. Ekaterina Dadachova, Ruth Bryan, Zewei Jiang, Arturo Casadevall, Alfred Morgenstern, Frank Bruchertseifer.
Alle Infos zum Namen "Frank Bruchertseifer"
sortiert nach Relevanz / Datum